b12 and lipotropic injections for weight loss Weightloss (MIC+ B12): Shot Medical Weight Loss | Lipotropic

The typical dosage range for AOD-9604 varies by administration route

- Cardiac glycosides: May increase the possibility of arrhythmias or increase digitalis toxicity associated with hypokalemia

Malabsorption can cause severe B12 deficiency

What they found: In normal obese mice: AOD-9604 reduced body fat by 21 % vs placebo, hGH by 24 % The AOD-9604 effect was fully dependent on the 3-adrenergic receptor , in knock-out mice no effect The hGH effect was partly independent of 3-AR , in knock-out mice there was still ~10 % fat reduction AOD-9604 did not raise IGF-1 (control level), whereas hGH raised IGF-1 by 80 % No changes in growth, organ weights (except adipose tissue), fasting insulin Why it matters: The study provided the mechanistic basis for AOD-9604 and confirmed the key business hypothesis: it is possible to separate the lipolytic effect of GH from its growth effect

Therefore, in one person, it may trigger excess histamine release, causing the symptoms of histamine intolerance, while in another person, it may not cause any symptoms

The injection is often very painful, and experience has shown that the risks outweigh the benefits